Acute‐phase response · people with familial Mediterranean fever
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Live birth rate · women trying to conceive by intrauterine insemination
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Ongoing pregnancy · women trying to conceive by intrauterine insemination
It is very uncertain whether oral progesterone changes ongoing pregnancy rate compared with vaginal progesterone (very low certainty).
1 finding from 1 review
Miscarriage per clinical pregnancy · women trying to conceive by intrauterine insemination
It is very uncertain whether oral progesterone changes miscarriage rate per clinical pregnancy compared with vaginal progesterone (very low certainty).
1 finding from 1 review
Clinical pregnancy rate · women trying to conceive by intrauterine insemination
It is very uncertain whether oral progesterone changes clinical pregnancy rate compared with vaginal progesterone (very low certainty).
1 finding from 1 review
Multiple pregnancy rate · women trying to conceive by intrauterine insemination
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events, OHSS, preterm delivery, congenital anomaly · women trying to conceive by intrauterine insemination
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Presence of dry socket · Adults (>18 years) having permanent tooth extraction (predominantly mandibular third molars)
Oral tissue patch led to lower presence of dry socket compared with placebo or control; GRADE not reported.
1 finding from 1 review
Primary outcome: complete clinical response (malar/discoid rash) · patients with cutaneous disease in systemic lupus erythematosus
Oral methotrexate may leads to higher primary outcome: complete clinical response (malar/discoid rash) compared with placebo (low certainty).
1 finding from 1 review
Primary outcome: partial clinical response · patients with cutaneous disease in systemic lupus erythematosus
1 finding from 1 review
Secondary outcome: clinical flare · patients with cutaneous disease in systemic lupus erythematosus
Oral methotrexate showed no clear difference in secondary outcome: clinical flare compared with placebo (moderate certainty).
1 finding from 1 review
Secondary outcome: CLASI · patients with cutaneous disease in systemic lupus erythematosus
1 finding from 1 review
Secondary outcome: Dermatology Quality of Life measure · patients with cutaneous disease in systemic lupus erythematosus
1 finding from 1 review
Adverse events: severe · patients with cutaneous disease in systemic lupus erythematosus
Oral methotrexate showed no clear difference in adverse events: severe compared with placebo (moderate certainty).
1 finding from 1 review
Minor adverse events · patients with cutaneous disease in systemic lupus erythematosus
Oral methotrexate showed no clear difference in adverse events: minor compared with placebo (moderate certainty).
1 finding from 1 review
Ocular chlamydia trachomatis infection · people (any age) with active trachoma
The review found no eligible studies for this question.
1 finding from 1 review
Antibiotics for trachoma 2019 · Cochrane Headline outcomes only no estimate extracted
Studies not reported
No studies found
Antibiotic resistance · people (any age) with active trachoma
Oral azithromycin led to lower antibiotic resistance Proportion of samples showing evidence of… compared with control; GRADE not reported.
1 finding from 1 review
Adverse effects · people (any age) with active trachoma
1 finding from 1 review
Active trachoma · people (any age) with active trachoma
1 finding from 1 review
Ocular chlamydia trachomatis infection · people (any age) with active trachoma
1 finding from 1 review